ALK-Positive Large B-Cell Lymphoma
Also known as: Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma / ALK-positive Diffuse Large B-cell Lymphoma / Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma / Anaplastic lymphoma kinase positive large B-cell lymphoma (disorder) / Anaplastic lymphoma kinase positive large B-cell lymphoma (morphologic abnormality) / Diffuse large B-cell lymphoma / Diffuse large B cell malignant lymphoma (morphologic abnormality) / Diffuse large B-cell lymphomas / Diffuse large B-cell lymphoma NOS / Diffuse non-Hodgkin's lymphoma, large cell (disorder) / Lymphoma, Large B-Cell, Diffuse
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB02379 | Beta-D-Glucose | 1 | Recruiting | 1 |
| DB14681 | Cortisone | 1 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB00694 | Daunorubicin | 1 | Recruiting | 1 |
| DB00997 | Doxorubicin | 1 | Recruiting | 1 |
| DB00773 | Etoposide | 1 | Recruiting | 1 |
| DB00099 | Filgrastim | 1 | Recruiting | 1 |
| DB12240 | Polatuzumab vedotin | 1 | Recruiting | 1 |
| DB00635 | Prednisone | 1 | Recruiting | 1 |
| DB00073 | Rituximab | 1 | Recruiting | 1 |
| DB15719 | Belantamab mafodotin | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB11930 | Varlilumab | 2 | Active Not Recruiting | 1 |